PharmD Info

A forum for Indian Pharmacy Professionals

Discuss and Learn about ADR monitoring techniques, ADR reporting forms, Indian ADR centers, ADR Mobile application, ADR management and etc.
  • User avatar
#2479
One stat that defines all the problem with Pharmacovigilance in India. Sun Pharmaceutical Industries Limited, which is the market leader in the Indian Pharmaceutical Market space reported only one (01) report of Adverse Drug Reaction with all its product for the month November-2017. Compare this to Novartis which reported 262 reports during the same duration, Pfizer reported 70, Bayer reported 135, Glaxo 37, and Roche 36.

Clearly home grown generic companies are either not taking pharmacovigilance too strictly or the reporters are missing out on reporting adverse events with generics. Or perhaps the old classical that reporting safety information for newer products is more important than safety information for generics/ established products.

PvPI ADRs Reporting Status–November, 2017
Attachments:
ADR - Pharma Companies.jpg
ADR - Pharma Companies.jpg (126.84 KiB) Viewed 3614 times
Similar Topics
Topics Statistics Last post
0 Replies 
4363 Views
by Admin
08 Dec 2016, 10:27
0 Replies 
4451 Views
by Admin
20 Mar 2017, 21:59
0 Replies 
3934 Views
by Admin
04 Jan 2017, 19:32
1 Replies 
7236 Views
by b4usp
14 Mar 2017, 14:36
0 Replies 
4138 Views
by Admin
04 Jan 2017, 20:08

This is an online survey to know the best pharmace[…]

Sun Pharma - In this post we listed all the import[…]

Login or Register the KSPC - Kerala State Pharmacy[…]

PCI - Pharmacy Council of India approves the pharm[…]

Join Us Today